Background: The COVID-19 pandemic was an unprecedented global health crisis. Vulnerable populations with preexisting mental illness have been disproportionately burdened and may experience adverse mental health outcomes related to the COVID-19 pandemic.
Objectives: Our objective was to evaluate the association between COVID-19 diagnosis, known exposure to COVID-19, sheltering in place, symptom severity, psychological distress, and depression severity among adults with severe mental illness (SMI).
Methods: In a cross-sectional study, participants were recruited among patients with SMI who visited an urban community health center in Georgia between February 1, 2019, and March 11, 2021. Measures included COVID-19 impacts on the symptoms of schizophrenia and other psychotic disorders, and severe mood disorders with psychotic features, depression symptoms, self-reported psychological distress, and social connectedness.
Results: Adults diagnosed with COVID-19 experienced more severe psychological distress (odds ratio [OR] = 2.48, 95% CI, 1.02–6.28) compared to those not diagnosed with COVID-19. After adjusting for sex and age, adults with SMI who sheltered in place during the lockdown experienced higher psychological distress than those who did not (adjusted odds ratio [aOR] = 2.52, 95% CI, 1.02–6.48). Women experienced significantly higher SMI severity (Brief Psychiatric Rating Scale scores [x̄
± SD] for women =56.7 ±24.4 vs men = 48.5± 19.1; [P= .039]) and higher odds of depression (OR = 2.74, 95% CI, 1.22–6.13) during the pandemic than men. Furthermore, adults with SMI with high social support experienced higher psychological distress than those with low social support (aOR = 4.60, 95% CI, 1.82–11.8).
Conclusions: The findings of this study emphasized the need to incorporate infectious disease responses with mental health interventions during a public health crisis.
J Clin Psychiatry 2025;86(1):24m15448
Author affiliations are listed at the end of this article.
Continue Reading...
Members enjoy unlimited free PDF downloads as part of their subscription! Subscribe today for instant access to this article and our entire library in your preferred format. Alternatively, you can purchase the PDF of this article individually.
Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in The United States: Results From The 2019 National Survey On Drug Use And Health (HHS Publication No. PEP20-07-01-001, NSDUH Series H-55). Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. 2020. Accessed February, 12, 2021. https://www.samhsa.gov/data
National Center for Health Statistics (U.S.). Health, United States, 2016: With Chartbook on Long-Term Trends in Health. 2017. Accessed May 17, 2021.
Hiscott J, Alexandridi M, Muscolini M, et al. The global impact of the coronavirus pandemic. Cytokine Growth Factor Rev. 2020;53:1–9. CrossRef
Hossain MM, Sultana A, Purohit N. Mental health outcomes of quarantine and isolation for infection prevention: a systematic umbrella review of the global evidence. Epidemiol Health. 2020;42:e2020038. PubMedCrossRef
Moore RC, Depp CA, Harvey PD, et al. Assessing the real-time mental health challenges of COVID-19 in individuals with serious mental illnesses: protocol for a quantitative study. JMIR Res Protoc. 2020;9(5):e19203. PubMedCrossRef
Sukut O, Ayhan Balik CH. The impact of COVID-19 pandemic on people with severe mental illness. Perspect Psychiatr Care. 2021;57(2):953–956.
Hossain MM, Tasnim S, Sultana A, et al. Epidemiology of mental health problems in COVID-19: a review. F1000Res. 2020;9:636. CrossRef
Bo H-X, Li W, Yang Y, et al. Posttraumatic stress symptoms and attitude toward crisis mental health services among clinically stable patients with COVID-19 in China. Psychol Med. 2021;51(6):1052–1053. PubMedCrossRef
Brooks SK, Webster RK, Smith LE, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020;395(10227):912–920. PubMedCrossRef
Czeisler MÉ, Lane RI, Petrosky E, et al. Mental health, substance use, and suicidal ideation during the COVID-19 pandemic—United States, June 24–30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(32):1049–1057. PubMedCrossRef
Fisher J, Tran T, Hammarberg K, et al. Quantifying the mental health burden of the most severe Covid-19 restrictions: a natural experiment. J Affect Disord. 2021;293:406–414. PubMedCrossRef
González-Blanco L, Dal Santo F, García-Álvarez L, et al. COVID-19 lockdown in people with severe mental disorders in Spain: do they have a specific psychological reaction compared with other mental disorders and healthy controls?. Schizophr Res. 2020;223:192–198. PubMedCrossRef
Hao F, Tan W, Jiang L, et al. Do psychiatric patients experience more psychiatric symptoms during COVID-19 pandemic and lockdown? A case-control study with service and research implications for immunopsychiatry. Brain Behav Immun. 2020;87:100–106. PubMedCrossRef
Iasevoli F, Fornaro M, D’Urso G, et al. Psychological distress in patients with serious mental illness during the COVID-19 outbreak and one-month mass quarantine in Italy. Psychol Med. 2021;51(6):1054–1056. PubMedCrossRef
Lee JY, Kim YJ, Chung EH, et al. The clinical and virological features of the first imported case causing MERS-CoV outbreak in South Korea, 2015. BMC Infect Dis. 2017;17(1):498. PubMedCrossRef
Liu X, Lin H, Jiang H, et al. Clinical characteristics of hospitalised patients with schizophrenia who were suspected to have coronavirus disease (COVID-19) in Hubei Province, China. Gen Psychiatr. 2020;33(2):e100222. PubMedCrossRef
Qiu J, Shen B, Zhao M, et al. A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendations. Gen Psychiatr. 2020;33(2):e100213. PubMedCrossRef
Rogers JP, Chesney E, Oliver D, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7(7):611–627. PubMedCrossRef
Rohde C, Jefsen OH, Norremark B, et al. Psychiatric symptoms related to the COVID-19 pandemic. Acta Neuropsychiatr. 2020;32(5):274–276. CrossRef
Taquet M, Geddes JR, Husain M, et al. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8(5):416–427. PubMedCrossRef
Taquet M, Luciano S, Geddes JR, et al. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID 19 cases in the USA. Lancet Psychiatry. 2021;8(2):130–140. PubMedCrossRef
Vissink CE, van Hell HH, Galenkamp N, et al. The effects of the COVID-19 outbreak and measures in patients with a pre-existing psychiatric diagnosis: a cross-sectional study. J Affect Disord Rep. 2021;4:100102. PubMedCrossRef
Wang Q, Xu R, Volkow ND. Increased risk of COVID-19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States. World Psychiatry. 2021;20(1):124–130. PubMedCrossRef
Yang L, Wu D, Hou Y, et al. Analysis of psychological state and clinical psychological intervention model of patients with COVID-19. J medRxiv. 2020; 20040899. doi:10.1101/2020.03.22.20040899 CrossRef
Krive J, Patel M, Gehm L, et al. The complexity and challenges of the international classification of diseases, ninth revision, clinical modification to international classification of diseases, 10th revision, clinical modification transition in EDs. Am J Emerg Med, 2015;33(5):713–718. PubMedCrossRef
Zhang J, Yang Z, Wang X, et al. The relationship between resilience, anxiety and depression among patients with mild symptoms of COVID-19 in China: a cross sectional study. J Clin Nurs. 2020;29(21–22):4020–4029.
Faul F, Erdfelder E, Buchner A, et al. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009;41(4):1149–1160. CrossRef
Culverhouse BA, Martin AR. Forced business closures: executive orders by the governor closing private businesses. GSULR. 2020;37(1):111.
Andersen J, Larsen J, Kørner A, et al. The brief psychiatric rating scale: schizophrenia, reliability and validity studies. Nordic J Psychiatry. 2009;40:135–138. CrossRef
Hofmann AB, Schmid HM, Jabat M, et al. Utility and validity of the brief psychiatric rating scale (BPRS) as a transdiagnostic scale. Psychiatry Res. 2022;314:114659. PubMedCrossRef
Zanello A, Berthoud L, Ventura J, et al. The Brief Psychiatric Rating Scale (version 4.0) factorial structure and its sensitivity in the treatment of outpatients with unipolar depression. Psychiatry Res. 2013;210(2):626–633. PubMedCrossRef
Park S-C, Jang EY, Kim K, et al. Establishing the cut-off scores for the severity ranges of schizophrenia on the BPRS-6 scale: findings from the REAP-AP. Psychiatry Clin Psychopharmacol. 2019;29(4):895–898. CrossRef
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613. PubMedCrossRef
Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary care evaluation of mental disorders. Patient health Questionnaire. JAMA. 1999;282(18):1737–1744. PubMed
Adams DP, Holt JR, Martin JA, et al. The effect of COVID-19 lockdown on PHQ depression screening scores for high school athletes. Int J Environ Res Public Health. 2022;19(16):9943. PubMedCrossRef
Stolk Y, Kaplan I, Szwarc J. Clinical use of the Kessler psychological distress scales with culturally diverse groups. Int J Methods Psychiatr Res. 2014;23(2):161–183. PubMedCrossRef
Kantamneni N. The impact of the COVID-19 pandemic on marginalized populations in the United States: a research agenda. J Vocat Behav. 2020;119:103439. PubMedCrossRef
Lemieux CM, Richards KN, Hunter DR, et al. Interrelationships among physical health, health-related, and psychosocial characteristics of persons receiving integrated care in community mental health settings. J Soc Serv Res. 2015;41(5):561–583. CrossRef
Lee RM, Draper M, Lee SJJ. Social connectedness, dysfunctional interpersonal behaviors, and psychological distress: testing a mediator model. J Couns Psychol. 2001;48(3):310–318. CrossRef
DiMaggio C. SAS for Epidemiologists: Applications and Methods. Springer; 2013.
Lee SW, Yang JM, Moon SY, et al. Association between mental illness and COVID-19 susceptibility and clinical outcomes in South Korea: a nationwide cohort study. Lancet Psychiatry. 2020;7(12):1025–1031. PubMedCrossRef
Wolf MS, Serper M, Opsasnick L, et al. Awareness, attitudes, and actions related to COVID-19 among adults with chronic conditions at the onset of the US outbreak: a cross-sectional survey. Ann Intern Med. 2020;173(2):100–109. PubMedCrossRef
Zhong B-L, Luo W, Li H-M, et al. Knowledge, attitudes, and practices towards COVID-19 among Chinese residents during the rapid rise period of the COVID-19 outbreak: a quick online cross-sectional survey. Int J Biol Sci. 2020;16(10):1745–1752. PubMedCrossRef
Gourovitch M, Goldberg T. Cognitive deficits in schizophrenia: attention, executive functions, memory and language processing. Schizophr a Neuropsychol Perspect. 1996:72–86.
McKenna PJ. Schizophrenia and Related Syndromes. Routledge; 2013.
Fagiolini A, Goracci A. The effects of undertreated chronic medical illnesses in patients with severe mental disorders. J Clin Psychiatry. 2009;70(Suppl 3):22–29. PubMedCrossRef
Colton CW, Manderscheid RW. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis. 2006;3(2):A42. PubMed
DE Hert M, Correll CU, Bobes J, et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry. 2011;10(1):52–77. PubMedCrossRef
Bzdok D, Dunbar RIM. The neurobiology of social distance. Trends Cogn Sci. 2020;24(9):717–733. PubMedCrossRef
Cresswell CM, Kuipers L, Power MJ. Social networks and support in long-term psychiatric patients. Psychol Med. 1992;22(4):1019–1026. PubMedCrossRef
Giallonardo V, Sampogna G, Del Vecchio V, et al. The impact of quarantine and physical distancing following COVID-19 on mental health: study protocol of a multicentric Italian population trial. Front Psychiatry. 2020;11:533. PubMedCrossRef
Gao J, Zheng P, Jia Y, et al. Mental health problems and social media exposure during COVID-19 outbreak. PLoS One. 2020;15(4):e0231924. PubMedCrossRef
Neria Y, Sullivan GM. Understanding the mental health effects of indirect exposure to mass trauma through the media. JAMA. 2011;306(12):1374–1375. PubMedCrossRef
Chow JC, Jaffee K, Snowden L. Racial/ethnic disparities in the use of mental health services in poverty areas. Am J Public Health. 2003;93(5):792–797. PubMedCrossRef
McGinty EE, Baller J, Azrin ST, et al. Quality of medical care for persons with serious mental illness: a comprehensive review. Schizophr Res. 2015;165(2–3):227–235. PubMedCrossRef